In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Additionally, Recursion shared promising results from its ongoing Phase 1b/2 TUPELO trial for the drug REC-4881, showing significant polyp reduction in patients with familial adenomatous polyposis.

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Investing.com -- Recursion Pharmaceuticals (NASDAQ:RXRX) stock rose 7% Monday following positive Phase 2 trial results for its experimental drug REC-4881 in familial adenomatous polyposis (FAP), a ...

Hi, everyone, and welcome. I'm Najat Khan, Recursion's Chief R&D and Chief Commercial Officer and incoming CEO and President. Let's jump right in. Today is an important moment for Recursion, for our ...

Scientists and researchers exploring a high plain near the pyramid complex have documented massive bedrock shafts, sealed openings, and signs of extensive underground construction. Many of these ...

In Eastern Europe, archaeologists uncovered circular accumulations of mammoth bones dating back 44,000 years. Found at the site of Molodova I in Ukraine, these structures were created by Neanderthals ...

From emails to social media to online shopping, banking and chatting — everything we rely on everyday goes through an AI data center. The biggest concentration of those centers anywhere in the world ...

Harbhajan Singh lashes out at Virat Kohli, Rohit Sharma critics Harbhajan Singh has strongly defended Virat Kohli and Rohit Sharma, lashing out at their critics for constantly questioning two of India ...